ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620129 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620129; 2) Community: the network communities that were significantly associated with the response to NSC 620129; 3) Molecule: the relationships between components within communities and NSC 620129; 4) MDR: the compounds that were significantly associated with the NSC 620129.

NSC Compound Enrichment Correlation
NSC 685285 Null 0.0329129886465387 0.071277452
NSC 686393 Null 0.0329129886465387 -0.036818195
NSC 686551 Null 0.0329129886465387 0.30469696
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.0329129886465387 0.019931861
NSC 718564 Null 0.0329129886465387 0.20914447
NSC 727113 Null 0.0329129886465387 0.3019704
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0329129886465387 -0.23817401
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0329129886465387 0.2164498
NSC 734949 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide 0.0329129886465387 0.20044438
NSC 749600 Null 0.0329129886465387 0.32886173
Total:74  Current:54    [First] [Prev] [Next] [Last]